264 related articles for article (PubMed ID: 27622063)
21. Acute aerobic exercise induces a preferential mobilisation of plasmacytoid dendritic cells into the peripheral blood in man.
Brown FF; Campbell JP; Wadley AJ; Fisher JP; Aldred S; Turner JE
Physiol Behav; 2018 Oct; 194():191-198. PubMed ID: 29763678
[TBL] [Abstract][Full Text] [Related]
22. Novel role of plasmacytoid dendritic cells in humans: induction of interleukin-10-producing Treg cells by plasmacytoid dendritic cells in patients with rheumatoid arthritis responding to therapy.
Kavousanaki M; Makrigiannakis A; Boumpas D; Verginis P
Arthritis Rheum; 2010 Jan; 62(1):53-63. PubMed ID: 20039433
[TBL] [Abstract][Full Text] [Related]
23. Cross-Presentation of the Oncofetal Tumor Antigen 5T4 from Irradiated Prostate Cancer Cells--A Key Role for Heat-Shock Protein 70 and Receptor CD91.
Salimu J; Spary LK; Al-Taei S; Clayton A; Mason MD; Staffurth J; Tabi Z
Cancer Immunol Res; 2015 Jun; 3(6):678-88. PubMed ID: 25678582
[TBL] [Abstract][Full Text] [Related]
24. Immunogenic Cell Death in Cancer Therapy.
Troitskaya OS; Novak DD; Richter VA; Koval OA
Acta Naturae; 2022; 14(1):40-53. PubMed ID: 35441043
[TBL] [Abstract][Full Text] [Related]
25. Chemotherapeutic and targeted drugs-induced immunogenic cell death in cancer models and antitumor therapy: An update review.
Zhai J; Gu X; Liu Y; Hu Y; Jiang Y; Zhang Z
Front Pharmacol; 2023; 14():1152934. PubMed ID: 37153795
[TBL] [Abstract][Full Text] [Related]
26. Oncolytic measles virus induces tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated cytotoxicity by human myeloid and plasmacytoid dendritic cells.
Achard C; Guillerme JB; Bruni D; Boisgerault N; Combredet C; Tangy F; Jouvenet N; Grégoire M; Fonteneau JF
Oncoimmunology; 2017; 6(1):e1261240. PubMed ID: 28197384
[TBL] [Abstract][Full Text] [Related]
27. Oxaliplatin induces immunogenic cells death and enhances therapeutic efficacy of checkpoint inhibitor in a model of murine lung carcinoma.
Sun F; Cui L; Li T; Chen S; Song J; Li D
J Recept Signal Transduct Res; 2019 Jun; 39(3):208-214. PubMed ID: 31441696
[No Abstract] [Full Text] [Related]
28. Heat shock treatment of tumor lysate-pulsed dendritic cells enhances their capacity to elicit antitumor T cell responses against medullary thyroid carcinoma.
Bachleitner-Hofmann T; Strohschneider M; Krieger P; Sachet M; Dubsky P; Hayden H; Schoppmann SF; Pfragner R; Gnant M; Friedl J; Stift A
J Clin Endocrinol Metab; 2006 Nov; 91(11):4571-7. PubMed ID: 16954161
[TBL] [Abstract][Full Text] [Related]
29. Immunogenic effects of chemotherapy-induced tumor cell death.
Wang YJ; Fletcher R; Yu J; Zhang L
Genes Dis; 2018 Sep; 5(3):194-203. PubMed ID: 30320184
[TBL] [Abstract][Full Text] [Related]
30. Cisplatin and oxaliplatin induce similar immunogenic changes in preclinical models of head and neck cancer.
Park SJ; Ye W; Xiao R; Silvin C; Padget M; Hodge JW; Van Waes C; Schmitt NC
Oral Oncol; 2019 Aug; 95():127-135. PubMed ID: 31345380
[TBL] [Abstract][Full Text] [Related]
31. Shikonin-enhanced cell immunogenicity of tumor vaccine is mediated by the differential effects of DAMP components.
Lin TJ; Lin HT; Chang WT; Mitapalli S P; Hsiao PW; Yin SY; Yang NS
Mol Cancer; 2015 Sep; 14():174. PubMed ID: 26403780
[TBL] [Abstract][Full Text] [Related]
32. Molecular pathways: the immunogenic effects of platinum-based chemotherapeutics.
Hato SV; Khong A; de Vries IJ; Lesterhuis WJ
Clin Cancer Res; 2014 Jun; 20(11):2831-7. PubMed ID: 24879823
[TBL] [Abstract][Full Text] [Related]
33. BET bromodomain inhibitor JQ1 promotes immunogenic cell death in tongue squamous cell carcinoma.
Wang M; Zhao L; Tong D; Yang L; Zhu H; Li Q; Zhang F
Int Immunopharmacol; 2019 Nov; 76():105921. PubMed ID: 31600692
[TBL] [Abstract][Full Text] [Related]
34. Dendritic cells pulsed with generated tumor cell lysate from Phyllanthus amarus Schum. & Thonn. induces anti-tumor immune response.
Mohamed SIA; Jantan I; Nafiah MA; Seyed MA; Chan KM
BMC Complement Altern Med; 2018 Aug; 18(1):232. PubMed ID: 30081891
[TBL] [Abstract][Full Text] [Related]
35. Circulating CD1c(+) DCs are superior at activating Th2 responses upon Phl p stimulation compared with basophils and pDCs.
Rydnert F; Lundberg K; Greiff L; Lindstedt M
Immunol Cell Biol; 2014 Jul; 92(6):557-60. PubMed ID: 24687020
[TBL] [Abstract][Full Text] [Related]
36. Dysfunctional TLR1 reduces the therapeutic efficacy of chemotherapy by attenuating HMGB1-mediated antitumor immunity in locally advanced colorectal cancer.
Huang KC; Ke TW; Chen JY; Hong WZ; Chiang SF; Lai CY; Chen TW; Yang PC; Chen LC; Liang JA; Chen WT; Chao KSC
Sci Rep; 2023 Nov; 13(1):19440. PubMed ID: 37945630
[TBL] [Abstract][Full Text] [Related]
37. Dynamical Boolean Modeling of Immunogenic Cell Death.
Checcoli A; Pol JG; Naldi A; Noel V; Barillot E; Kroemer G; Thieffry D; Calzone L; Stoll G
Front Physiol; 2020; 11():590479. PubMed ID: 33281620
[TBL] [Abstract][Full Text] [Related]
38. Primary Human Blood Dendritic Cells for Cancer Immunotherapy-Tailoring the Immune Response by Dendritic Cell Maturation.
Sittig SP; de Vries IJM; Schreibelt G
Biomedicines; 2015 Dec; 3(4):282-303. PubMed ID: 28536413
[TBL] [Abstract][Full Text] [Related]
39.
Turrini E; Catanzaro E; Muraro MG; Governa V; Trella E; Mele V; Calcabrini C; Morroni F; Sita G; Hrelia P; Tacchini M; Fimognari C
Oncotarget; 2018 May; 9(36):24443-24456. PubMed ID: 29849952
[TBL] [Abstract][Full Text] [Related]
40. Dinaciclib induces immunogenic cell death and enhances anti-PD1-mediated tumor suppression.
Hossain DMS; Javaid S; Cai M; Zhang C; Sawant A; Hinton M; Sathe M; Grein J; Blumenschein W; Pinheiro EM; Chackerian A
J Clin Invest; 2018 Feb; 128(2):644-654. PubMed ID: 29337311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
